Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Toll-like receptor signaling pathway	6/104	3.2067296679247765e-10	2.6295183276983166e-08	162.6734693877551	-375.80372920249886	MYD88;NFKB1;TLR3;TLR4;TLR5;TRAF6
KEGG_2021_Human	Hepatitis B	5/162	3.601936059275885e-07	9.845291895354086e-06	62.99363057324841	-170.1050524604851	MYD88;NFKB1;TLR3;TLR4;TRAF6
KEGG_2021_Human	Legionellosis	4/57	2.7344275530896155e-07	9.845291895354086e-06	120.99622641509434	-237.01297955195037	MYD88;NFKB1;TLR4;TLR5
KEGG_2021_Human	Leishmaniasis	4/77	9.275084931179923e-07	1.3044198177586392e-05	87.62739726027397	-186.6153313850638	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Pertussis	4/76	8.797646849986461e-07	1.3044198177586392e-05	88.85555555555555	-188.59549699748743	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Pathogenic Escherichia coli infection	5/197	9.544535251892481e-07	1.3044198177586392e-05	51.282552083333336	-143.27660157703332	MYD88;NFKB1;TLR4;TLR5;TRAF6
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	1.6634572452980364e-06	1.9486213444919853e-05	75.1435294117647	-165.83662359264343	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Coronavirus disease	5/232	2.147007157098092e-06	2.1246782754857604e-05	43.18281938325991	-123.5674188696757	MYD88;NFKB1;TLR3;TLR4;TRAF6
KEGG_2021_Human	Chagas disease	4/102	2.8764653138476235e-06	2.1246782754857604e-05	65.06938775510204	-148.10223758354354	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	NF-kappa B signaling pathway	4/104	3.1092852811986736e-06	2.1246782754857604e-05	63.752	-145.71127254838157	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Shigellosis	5/246	2.86800965527578e-06	2.1246782754857604e-05	40.601659751037346	-117.05617955492606	MYD88;NFKB1;TLR4;TLR5;TRAF6
KEGG_2021_Human	Salmonella infection	5/249	3.044854301540671e-06	2.1246782754857604e-05	40.08709016393443	-115.7436620154157	MYD88;NFKB1;TLR4;TLR5;TRAF6
KEGG_2021_Human	Toxoplasmosis	4/112	4.1830414517494515e-06	2.6385338387958078e-05	58.97037037037037	-136.88039734610902	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Yersinia infection	4/137	9.341058998242965e-06	5.409272113984792e-05	47.73533834586466	-115.08325950004442	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Measles	4/139	9.895009964606327e-06	5.409272113984792e-05	47.0162962962963	-113.6324399180788	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Influenza A	4/172	2.3010807243183006e-05	0.0001179303871213129	37.62380952380953	-93.9608075055161	MYD88;NFKB1;TLR3;TLR4
KEGG_2021_Human	Tuberculosis	4/180	2.7532407632704863e-05	0.0001281954111721341	35.877272727272725	-90.14040840186996	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	NOD-like receptor signaling pathway	4/181	2.8140456110956267e-05	0.0001281954111721341	35.67005649717514	-89.68342157258434	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Inflammatory bowel disease	3/65	4.035757656486071e-05	0.0001741748041220304	64.5725806451613	-110.56953939917612	NFKB1;TLR4;TLR5
KEGG_2021_Human	Human immunodeficiency virus 1 infection	4/212	5.2397739445771114e-05	0.00021483073172766156	30.234615384615385	-77.39428194884488	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Lipid and atherosclerosis	4/215	5.536552922333184e-05	0.00021618920934824814	29.793364928909952	-76.36955702954943	MYD88;NFKB1;TLR4;TRAF6
KEGG_2021_Human	Hepatitis C	3/157	0.000555171423312075	0.0020692753050722793	25.698051948051948	-51.16015712271987	NFKB1;TLR3;TRAF6
KEGG_2021_Human	Epstein-Barr virus infection	3/202	0.0011578075203868253	0.0041278355074660725	19.77386934673367	-40.07273905953756	MYD88;NFKB1;TRAF6
KEGG_2021_Human	Malaria	2/50	0.0013147997999829724	0.004492232649941822	47.74404761904762	-54.846755239269285	MYD88;TLR4
KEGG_2021_Human	Herpes simplex virus 1 infection	4/498	0.0014016363558249402	0.004597367247105804	12.267206477732794	-31.38562786363473	MYD88;NFKB1;TLR3;TRAF6
KEGG_2021_Human	RIG-I-like receptor signaling pathway	2/70	0.00256220797992988	0.008080809782855775	33.61764705882353	-41.26579239949642	NFKB1;TRAF6
KEGG_2021_Human	MAPK signaling pathway	3/294	0.003404470153914145	0.01033950194892444	13.36426116838488	-27.04477578435615	MYD88;NFKB1;TRAF6
KEGG_2021_Human	Small cell lung cancer	2/92	0.004384956936205731	0.01284165959888821	25.33015873015873	-32.38073681020333	NFKB1;TRAF6
KEGG_2021_Human	IL-17 signaling pathway	2/94	0.004573450382906214	0.012931825220631365	24.773291925465838	-31.752738777128943	NFKB1;TRAF6
KEGG_2021_Human	Amoebiasis	2/102	0.00536466684441913	0.014663422708078955	22.768571428571427	-29.454947611395344	NFKB1;TLR4
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.006105352720275968	0.016149642679439656	21.26034712950601	-27.68582717074483	NFKB1;TLR4
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.007240587298154556	0.01855400495152105	19.418803418803417	-25.474864071873153	NFKB1;TRAF6
KEGG_2021_Human	Osteoclast differentiation	2/127	0.008213083210946173	0.020408267372654127	18.157714285714285	-23.926174303508194	NFKB1;TRAF6
KEGG_2021_Human	Necroptosis	2/159	0.012657031916689763	0.030525782857898844	14.398544131028208	-19.122798529767856	TLR3;TLR4
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.017593103320402977	0.041218127779229834	12.042780748663102	-15.950643243784452	NFKB1;TLR4
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.018305168945798957	0.04169510704320874	11.784592370979805	-15.594506527477616	NFKB1;TLR3
KEGG_2021_Human	African trypanosomiasis	1/37	0.04049551865831964	0.08974682513465435	27.89236111111111	-15.184460455315875	MYD88
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.04421159668343239	0.09540397179056463	7.199443413729128	-8.958659315132632	MIR146A;NFKB1
KEGG_2021_Human	Human papillomavirus infection	2/331	0.0498033032771934	0.10471463765973997	6.721667390360399	-8.231969519638584	NFKB1;TLR3
KEGG_2021_Human	Cocaine addiction	1/49	0.053312458983950796	0.10929054091709914	20.888020833333332	-11.903933011994981	NFKB1
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.05621963596091318	0.11243927192182636	6.263798701298701	-7.529666548445882	NFKB1;TLR4
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.06807303774497875	0.13290450226400613	16.143145161290324	-9.472518280745922	NFKB1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.07537632257699178	0.1343664880720288	14.492753623188406	-8.576836282024367	NFKB1
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.07433612093989085	0.1343664880720288	14.707720588235293	-8.695150624681633	NFKB1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.07537632257699178	0.1343664880720288	14.492753623188406	-8.576836282024367	NFKB1
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07225259654096947	0.1343664880720288	15.157196969696969	-8.940904692220872	NFKB1
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.08159574176033811	0.13939272550724427	13.323333333333334	-7.924002328332589	NFKB1
KEGG_2021_Human	Pancreatic cancer	1/76	0.08159574176033811	0.13939272550724427	13.323333333333334	-7.924002328332589	NFKB1
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.08675015538899065	0.14517372942647416	12.4828125	-7.444675790846853	NFKB1
KEGG_2021_Human	Insulin resistance	1/108	0.11414221216513072	0.15874978289792882	9.301401869158878	-5.5437021881688855	NFKB1
KEGG_2021_Human	Longevity regulating pathway	1/102	0.10811902604280113	0.15874978289792882	9.861386138613861	-5.889129551383326	NFKB1
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.1101307870056494	0.15874978289792882	9.66747572815534	-5.770076289156004	NFKB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.10610322337144797	0.15874978289792882	10.063131313131313	-6.012374432750834	NFKB1
KEGG_2021_Human	Th17 cell differentiation	1/107	0.11314086575838443	0.15874978289792882	9.390330188679245	-5.598891001043246	NFKB1
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.09799945337690771	0.15874978289792882	10.958791208791208	-6.552151761424751	NFKB1
KEGG_2021_Human	Prostate cancer	1/97	0.1030719256198476	0.15874978289792882	10.381510416666666	-6.205609665169881	NFKB1
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.1101307870056494	0.15874978289792882	9.66747572815534	-5.770076289156004	NFKB1
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.09901598291855658	0.15874978289792882	10.838315217391305	-6.480229695184393	TLR4
KEGG_2021_Human	Pathways in cancer	2/531	0.11422240476802195	0.15874978289792882	4.072373751012693	-4.112145636603806	NFKB1;TRAF6
KEGG_2021_Human	TNF signaling pathway	1/112	0.11813755546186366	0.16145465913121368	8.961711711711711	-5.331706526568274	NFKB1
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.1250908789190453	0.1681549519895363	8.422669491525424	-4.991352204954326	NFKB1
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.13493965981513528	0.17846858233614665	7.7548828125	-4.562741285776279	NFKB1
KEGG_2021_Human	Ubiquitin mediated proteolysis	1/140	0.14565938613127935	0.1833764634651495	7.131294964028777	-4.155247022438812	TRAF6
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.1446897687889315	0.1833764634651495	7.183876811594203	-4.189884821040622	NFKB1
KEGG_2021_Human	Apoptosis	1/142	0.14759569010609594	0.1833764634651495	7.028368794326241	-4.0872955859712885	NFKB1
KEGG_2021_Human	Autophagy	1/137	0.14274759908195303	0.1833764634651495	7.291360294117647	-4.260528287487475	TRAF6
KEGG_2021_Human	Cellular senescence	1/156	0.1610409501866746	0.19138199877256984	6.382258064516129	-3.656151305359152	NFKB1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.1600868648381378	0.19138199877256984	6.424512987012987	-3.684591600744329	NFKB1
KEGG_2021_Human	Phagosome	1/152	0.1572188193926902	0.19138199877256984	6.554635761589404	-3.771957076436021	TLR4
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.1947529189002049	0.22492590633544793	5.1557591623036645	-2.815647086064282	NFKB1
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.1947529189002049	0.22492590633544793	5.1557591623036645	-2.815647086064282	NFKB1
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.20662741093259937	0.2289655094117993	4.8192401960784315	-2.580067641436469	TLR4
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.20481075885442057	0.2289655094117993	4.868193069306931	-2.614463741813879	NFKB1
KEGG_2021_Human	Viral carcinogenesis	1/203	0.20481075885442057	0.2289655094117993	4.868193069306931	-2.614463741813879	NFKB1
KEGG_2021_Human	cAMP signaling pathway	1/216	0.21655321360035754	0.23654952276093652	4.566279069767442	-2.4016666931883877	NFKB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.21924102109550214	0.23654952276093652	4.501720183486238	-2.3559646623273536	NFKB1
KEGG_2021_Human	Human cytomegalovirus infection	1/225	0.22459205877125593	0.23917595869146738	4.377790178571429	-2.268046374240644	NFKB1
KEGG_2021_Human	Ras signaling pathway	1/232	0.23079371515646216	0.242629290292691	4.241341991341991	-2.1709758732309115	NFKB1
KEGG_2021_Human	Chemical carcinogenesis	1/239	0.2369512430560319	0.24594939152651413	4.112920168067227	-2.0793719054613833	NFKB1
KEGG_2021_Human	Endocytosis	1/252	0.24827051339380346	0.2544772762286486	3.893426294820717	-1.9223154882950422	TRAF6
KEGG_2021_Human	Alzheimer disease	1/369	0.34362041916781694	0.3478626465649505	2.615828804347826	-1.004788438682883	NFKB1
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.4205589366821036	0.4205589366821036	2.0029008438818567	-0.5780753067414636	NFKB1
